Edition:
United Kingdom

Marinus Pharmaceuticals Inc (MRNS.OQ)

MRNS.OQ on NASDAQ Stock Exchange Global Market

8.78USD
21 Sep 2018
Change (% chg)

$0.72 (+8.93%)
Prev Close
$8.06
Open
$8.04
Day's High
$8.92
Day's Low
$7.91
Volume
543,645
Avg. Vol
193,051
52-wk High
$9.86
52-wk Low
$3.31

Chart for

About

Marinus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing therapeutics to treat epilepsy and neuropsychiatric disorders. Its clinical-stage product candidate, ganaxolone, is a modulator being developed in various dose forms, including intravenous, oral... (more)

Overall

Beta: --
Market Cap(Mil.): $220.52
Shares Outstanding(Mil.): 31.75
Dividend: --
Yield (%): --

Financials

  MRNS.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -1.11 -- --
ROI: -85.78 15.07 14.61
ROE: -92.43 16.59 16.33

Earnings vs. Estimates